You will have probably seen that they just published results comparing to a standard of care diagnostic and will take it thru to FDA & TGA approval which shows openness, transparency and proper process. That is not what Theranos did.
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark, page-46
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
-0.005(1.14%) |
Mkt cap ! $35.49M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 42.5¢ | $61.14K | 139.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 31725 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 14271 | 2 |
View Market Depth
| Last trade - 15.48pm 16/08/2024 (20 minute delay) ? |
| COV (ASX) Chart |